Rapid phenotypic antimicrobial susceptibility testing using nanoliter arrays

Abstract

Antibiotic resistance is a major global health concern that requires action across all sectors of society. In particular, to allow conservative and effective use of antibiotics clinical settings require better diagnostic tools that provide rapid determination of antimicrobial susceptibility. We present a method for rapid and scalable antimicrobial susceptibility testing using stationary nanoliter droplet arrays that is capable of delivering results in approximately half the time of conventional methods, allowing its results to be used the same working day. In addition, we present an algorithm for automated data analysis and a multiplexing system promoting practicality and translatability for clinical settings. We test the efficacy of our approach on numerous clinical isolates and demonstrate a 2-d reduction in diagnostic time when testing bacteria isolated directly from urine samples.antibiotic resistance | nanoliter wells | antibiotic susceptibility testing | microfluidics | resazurin

Evaluation of bacterial proliferation with a microfluidic-based device: Antibiochip

“…The recently introduced technology by Accelerate Diagnostics uses morphokinetic cellular analysis to measure the capacity of a microbe to proliferate in the presence of an antibiotic [6]. At present, there is evidence that increasing the speed of the detection of antibiotic resistance is a real topic [7], [8,9], [10], [11]. In routine clinical microbiology settings, the time to measure antibiograms from an automated or manual system ranges from 6 to 12 hours.…”

Identification and Antibiotic‐Susceptibility Profiling of Infectious Bacterial Agents: A Review of Current and Future Trends

“…The platform consists of 200 wells of standard dimension to allow the trapping of an average 4CFU/well, which correspond to 5 × 10 5 CFU mL −1 , to improve the clinical translatability and interpretability, using standard breakpoints established by EUCAST and CLSI. As the clinical sample flows inside the antibiotic‐containing wells, the changes in fluorescence are proportional to the number of bacteria in the well, allowing to measure the efficacy of the antibiotic treatment in about 6 h …”

Why Can't We Just Use PCR? The Role of Genotypic versus Phenotypic Testing for Antimicrobial Resistance Testing

“…There is certainly enthusiasm for faster phenotypic AST from a variety of clinical specimens, as demonstrated by an influx of innovative strategies. Several approaches have been explored, including digital real-time loop-mediated isothermal amplification (dLAMP) [38] and partnering microfluidics with nanotechnology [39]. The dLAMP assay proposes phenotypic AST results within 30 min directly from clinical urine samples [38].…”